Results 211 to 220 of about 567,668 (313)

Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center. [PDF]

Pituitary
Prencipe N, Bona C, Cuboni D, Berton AM, Bioletto F, Varaldo E, Aversa LS, Sibilla M, Gasco V, Ghigo E, Grottoli S.   +10 more
europepmc   +1 more source

Cabergoline, Dopamine D2 Receptor Agonist, Prevents Neuronal Cell Death under Oxidative Stress via Reducing Excitotoxicity

, 2014
Haruki Odaka, Tadahiro Numakawa, Naoki Adachi, Yoshiko Ooshima, Shingo Nakajima, Yusuke Katanuma, Takafumi Inoue, Hiroshi Kunugi   +7 more
openalex   +2 more sources

Dopamine Agonists Upregulate IL-6 and IL-8 Production in Human Keratinocytes

Neuroimmunomodulation, 2012
A. C. Parrado, A. Canellada, T. Gentile, E. Rey-Roldán   +3 more
semanticscholar   +1 more source

Harnessing the Therapeutic Potential of Cell Secretomes and Extracellular Vesicles for Craniofacial Regenerative Applications

Journal of Periodontal Research, EarlyView.
The scoping review summarizes the current preclinical and clinical evidence for the use of “cell‐free” therapies in craniofacial (periodontal, bone and soft‐tissue) regeneration. It also aims to highlight key challenges and strategies towards the clinical translation of these therapies.
Siddharth Shanbhag, Magdalena Mayol, Danijel Domic, Madhusudhan Reddy Bobbili, Johannes Grillari, Mariano Sanz, Reinhard Gruber   +6 more
wiley   +1 more source

Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

New England Journal of Medicine, 2007
R. Zanettini, A. Antonini, G. Gatto, R. Gentile, S. Tesei, G. Pezzoli   +5 more
semanticscholar   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Dopamine agonists and the risk of cardiac-valve regurgitation.

New England Journal of Medicine, 2007
R. Schade, F. Andersohn, S. Suissa, W. Haverkamp, E. Garbe   +4 more
semanticscholar   +1 more source

Chronically elevated sympathetic nervous system tone: A significant, common, and poorly realised contributor to cardiometabolic disease in type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Ralph A. DeFronzo
wiley   +1 more source

Sex‐based disparities in dopamine agonist response in patients with restless legs syndrome

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary This study aimed to investigate sex‐related differences in the response to ropinirole and pramipexole in patients with restless legs syndrome (RLS). By analysing clinical parameters and polysomnographic (PSG) findings, we sought to elucidate the potential factors related to sex disparities modulating treatment responses and sleep quality in RLS.
Maria P. Mogavero, Elena Antelmi, Giuseppe Lanza, Sara Marelli, Alessandra Castelnuovo, Michele Tinazzi, Lourdes M. DelRosso, Rosalia Silvestri, Raffaele Ferri, Luigi Ferini Strambi   +9 more
wiley   +1 more source

Dopamine agonists and risk: impulse control disorders in Parkinson's disease.

Brain : a journal of neurology, 2011
V. Voon, Jennifer Gao, C. Brezing, M. Symmonds, V. Ekanayake, H. Fernandez, R. Dolan, M. Hallett   +7 more
semanticscholar   +1 more source